GENK
GEN Restaurant Group, Inc.
GENK trails on the overall score without a compensating advantage in the available component scores.
RIVN
Rivian Automotive, Inc.
RIVN has the edge over GENK overall, supported by stronger fundamentals and lower modeled downside.
GENK Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Under pressure | |
| Strong |
GENK's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
RIVN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
RIVN's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
GENK PE Valuation
GENK has no meaningful PE right now: it lost money over the past year.
RIVN PE Valuation
RIVN has no meaningful PE right now: it lost money over the past year.
GENK Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Stable | |
| Stable | |
| Limited | |
| High |
Analysts expect GENK's losses to shrink, with revenue holding steady.
RIVN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
RIVN has the edge over GENK on the outlook, with more favorable revenue and profitability expectations.
GENK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.89 | -$0.62 |
| Q2 2026 | -$0.84 | -$0.69 |
| Q1 2026 | -$0.75 | -$0.71 |
| Q4 2025 | -$0.59 | -554% |
| Q3 2025 | -$0.27 | -259% |
| Q2 2025 | -$0.15 | -163% |
| Q1 2025 | -$0.04 | -104% |
| Q4 2024 | $0.13 | -94% |
GENK lost $0.89 per share over the past year, and its loss has widened in each of the last 11 quarters.
RIVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.25 | +$0.83 |
| Q2 2026 | -$2.58 | +$0.62 |
| Q1 2026 | -$2.92 | +$0.77 |
| Q4 2025 | -$3.07 | +$1.62 |
| Q3 2025 | -$3.08 | +$2.52 |
| Q2 2025 | -$3.20 | +$2.76 |
| Q1 2025 | -$3.69 | +$2.08 |
| Q4 2024 | -$4.69 | +$1.05 |
RIVN has the edge over GENK on earnings, with more consistent year-over-year improvement.
GENK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $48.7M | -3.3% |
| Q2 2026 | $55.7M | +1.2% |
| Q1 2026 | $53.9M | -6% |
| Q4 2025 | $49.7M | -9% |
| Q3 2025 | $50.4M | +2.7% |
| Q2 2025 | $55M | +2.2% |
| Q1 2025 | $57.3M | +13% |
| Q4 2024 | $54.7M | +21% |
GENK's revenue is shrinking: $49M last quarter, down 3.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -12% | -5 points |
| Q2 2026 | -9.2% | -5.8 points |
| Q1 2026 | -13% | -9.6 points |
| Q4 2025 | -25% | -22 points |
| Q3 2025 | -7.4% | -7.6 points |
| Q2 2025 | -3.4% | -6.4 points |
| Q1 2025 | -3.8% | -4 points |
| Q4 2024 | -2.4% | -0.4 points |
GENK has the edge over RIVN on profitability, with a higher operating margin.
RIVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +38% |
| Q2 2026 | $1.7B | +27% |
| Q1 2026 | $1.4B | +11% |
| Q4 2025 | $1.3B | -26% |
| Q3 2025 | $1.6B | +78% |
| Q2 2025 | $1.3B | +13% |
| Q1 2025 | $1.2B | +3% |
| Q4 2024 | $1.7B | +32% |
RIVN has the edge over GENK on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -41% | +22 points |
| Q2 2026 | -50% | +35 points |
| Q1 2026 | -64% | -11 points |
| Q4 2025 | -65% | -27 points |
| Q3 2025 | -63% | +71 points |
| Q2 2025 | -86% | +33 points |
| Q1 2025 | -53% | +70 points |
| Q4 2024 | -38% | +82 points |
RIVN's operating margin was −41% last quarter, up 22 points from the same quarter a year ago, near the top of its range since 2021.
GENK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.9M | +$767K |
| Q2 2026 | -$5.5M | +$835K |
| Q1 2026 | -$667K | +$4M |
| Q4 2025 | -$5.6M | -3516% |
| Q3 2025 | -$7.7M | -$870K |
| Q2 2025 | -$6.3M | -605% |
| Q1 2025 | -$4.7M | -$4.1M |
| Q4 2024 | $165K | -83% |
GENK has burned cash in most quarters: −$19M over the past year, against −$19M the year before.
RIVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1B | -$703M |
| Q2 2026 | -$849M | -$451M |
| Q1 2026 | -$1.1B | -$549M |
| Q4 2025 | -$1.1B | -234% |
| Q3 2025 | -$421M | +$732M |
| Q2 2025 | -$398M | +$639M |
| Q1 2025 | -$526M | +$997M |
| Q4 2024 | $856M | +$2.3B |
RIVN has the edge over GENK on cash flow, with more consistent year-over-year improvement.
GENK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +17% | +935K shares |
| 1 year | +20% | +1.1M shares |
| 3 years | +52% | +2.2M shares |
| 5 years | +75% | +2.7M shares |
GENK has 6M diluted shares, up 20% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | $1,000 |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $200,000 |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $320,000 |
RIVN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9.1% | +121M shares |
| 1 year | +19% | +226M shares |
| 3 years | +52% | +494M shares |
RIVN has the edge over GENK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | $6M |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
GENK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2025 | -0.7x | Net Cash |
| Q1 2025 | -1.6x | Net Cash |
| Q4 2024 | -2.3x | Net Cash |
| Q3 2024 | -2.1x | Net Cash |
| Q2 2024 | -2.4x | Net Cash |
| Q1 2024 | -2.0x | Net Cash |
| Q4 2023 | -1.8x | Net Cash |
| Q3 2023 | -1.6x | Net Cash |
GENK has more cash than debt.
RIVN Net Leverage
RIVN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
GENK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 25.8 | Oversold |
| Stochastic | 5.4 | Oversold |
GENK's weekly RSI is 26 (oversold) and its Stochastic is 5 (oversold).
RIVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 25.6 | Neutral |
RIVN's weekly RSI is 41 (neutral) and its Stochastic is 26 (neutral).
GENK PE vs Consumer Cyclical Sector
| Metric | GENK | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
GENK has no meaningful PE right now: it lost money over the past year.
RIVN PE vs Consumer Cyclical Sector
RIVN has no meaningful PE right now: it lost money over the past year.
GENK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.49 | 36% below |
| 20 week MA | $1.75 | 45% below |
| 50 week MA | $1.91 | 50% below |
| 100 week MA | $3.17 | 70% below |
RIVN has stronger trend alignment. GENK is above 0 of 4 weekly averages versus RIVN above 0 of 5.
RIVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.3 | 3.9% below |
| 20 week MA | $15.1 | 15% below |
| 50 week MA | $15.9 | 19% below |
| 100 week MA | $14.7 | 13% below |
| 200 week MA | $15.1 | 15% below |
RIVN is in a downtrend: it's below all five of its weekly moving averages, and 15% below its 200-week average.
GENK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $17.0 | $7.83 | -54% |
| 2024 | $7.83 | $7.40 | -5.5% |
| 2025 | $7.40 | $2.41 | -67% |
| 2026 YTD | $2.41 | $0.96 | -60% |
GENK has finished every year since 2023 lower, and it's down 60% so far in 2026.
RIVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $130.0 | $96.8 | -25% |
| 2022 | $96.8 | $19.1 | -80% |
| 2023 | $19.1 | $23.5 | +23% |
| 2024 | $23.5 | $13.7 | -42% |
| 2025 | $13.7 | $20.9 | +53% |
| 2026 YTD | $20.9 | $12.8 | -39% |
RIVN has the edge over GENK on returns for 2026, with the stronger performance.